| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 213.861 | 184.658 | 179.198 | 170.363 | 157.415 | 133.713 | 148.563 | 162.780 | 145.133 | 158.358 |
| Total Income - EUR | 217.215 | 185.281 | 189.648 | 182.492 | 168.653 | 134.033 | 149.575 | 162.781 | 145.134 | 158.359 |
| Total Expenses - EUR | 216.134 | 191.112 | 192.617 | 188.303 | 167.918 | 145.698 | 139.371 | 151.277 | 156.983 | 166.860 |
| Gross Profit/Loss - EUR | 1.081 | -5.831 | -2.968 | -5.812 | 734 | -11.665 | 10.204 | 11.504 | -11.848 | -8.500 |
| Net Profit/Loss - EUR | 908 | -5.831 | -4.757 | -7.639 | -967 | -12.859 | 8.578 | 9.669 | -11.848 | -8.500 |
| Employees | 7 | 7 | 4 | 4 | 4 | 4 | 2 | 2 | 3 | 3 |
Check the financial reports for the company - Relifarm Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 85 | 62 | 39 | 16 | 0 | 555 | 395 | 248 | 149 | 50 |
| Current Assets | 61.063 | 67.313 | 66.255 | 56.284 | 49.604 | 47.091 | 49.727 | 64.455 | 44.418 | 44.845 |
| Inventories | 21.057 | 20.841 | 25.278 | 17.157 | 22.400 | 21.617 | 21.849 | 24.589 | 23.160 | 23.740 |
| Receivables | 31.963 | 18.503 | 31.253 | 31.258 | 23.902 | 21.654 | 26.455 | 36.936 | 18.853 | 17.909 |
| Cash | 8.042 | 27.969 | 9.724 | 7.869 | 3.302 | 3.820 | 1.422 | 2.930 | 2.406 | 3.196 |
| Shareholders Funds | 13.514 | 7.545 | 1.777 | -5.893 | -17.831 | -30.349 | -21.098 | -12.204 | -24.015 | -32.381 |
| Social Capital | 12.071 | 11.948 | 11.746 | 11.532 | 213 | 211 | 206 | 207 | 206 | 205 |
| Debts | 47.634 | 59.831 | 64.517 | 62.193 | 67.434 | 77.995 | 71.220 | 76.906 | 68.784 | 77.407 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Relifarm Srl